Viewing nowJanumet 25 mg (Sitagliptin Hydrochloride Monohydrate)
Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
HLB Pharmaceuticals Co., Ltd.

MFDS item code 202101226 · Approved 2021.02.10 · Insurance code 647304470
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to improve blood sugar control in patients with type 2 diabetes. It is primarily administered in conjunction with dietary modifications and exercise, and can also be used as monotherapy. If there is no prior experience with diabetes treatment and blood sugar control is difficult with monotherapy, it is used in combination with metformin. Additionally, when the blood sugar control is insufficient with any one of sulfonylureas, metformin, thiazolidinediones, or insulin, this medication is added. In cases where blood sugar control is difficult even with various combination therapies, this medication is used to enhance treatment efficacy. Thus, it effectively improves blood sugar control in various situations.
This medicine is administered at a dose of 100 mg once daily as monotherapy or in combination therapy. The maximum daily dose is 100 mg. This medicine may be taken with or without food. When used in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for use, section 5. General precautions). Patients with renal impairment Because dose adjustment based on renal function is necessary, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. 1. No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or patients with end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.
This medication may cause serious allergic reactions such as skin rash, anaphylaxis, and angioedema, so caution is needed. If symptoms of pancreatitis, such as abdominal pain, vomiting, or persistent abdominal discomfort occur during the use of this medication, consult a healthcare professional immediately. It should not be used by patients with type 1 diabetes, diabetic ketoacidosis, or those with hypersensitivity to this medication or its components. Patients with impaired kidney function should have their dosage adjusted, and regular monitoring of kidney function is important. Low blood sugar symptoms may occur while using this medication; therefore, glucose levels should be carefully monitored, especially when taken with insulin or sulfonylureas. This medication may cause side effects such as headache, upper respiratory tract infections, nasopharyngitis, diarrhea, nausea, etc., so report to a healthcare professional if symptoms are severe. If severe joint pain or symptoms resembling bullous pemphigoid occurs, immediately discontinue use and consult a healthcare professional. Pregnant or nursing women should avoid taking this medication, and safety in children and adolescents under 18 years of age has not been established. In the event of overdose, seek appropriate treatment at a hospital immediately, as this medication can be partially removed through hemodialysis. This medication has minimal drug interactions, but consult a healthcare professional when used in conjunction with specific medications. Elderly patients may have a reduced kidney function, so dosage adjustments and regular kidney function assessments are necessary.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to prevent air exposure and keep it at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the drug's efficacy for a longer time.
Pink, round, biconvex, film-coated tablet
28 tablets/box [14 tablets/PTP×2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
HLB Pharmaceuticals Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.